GLOBE Model (Part B Inflation Rebate Demonstration)

Current understanding

The Global Benchmark for Efficient Drug Pricing (GLOBE) Model is a mandatory CMS/CMMI demonstration that tests a new method for calculating inflation rebates on certain Medicare Part B drugs. CMS states the model aims to lower drug spending for traditional Medicare beneficiaries and the program without reducing care quality. Status: final rule establishing the mandatory test; it modifies rebate calculation methodology for covered Part B drugs within the demonstration scope rather than enacting a permanent statutory change.

Evidence log

Open questions

Related